The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward
Cara Cuenot, lead counsel for the BioCorrection Research Unit, Pfizer Inc, USA
Marc Wilenzick, Assistant General Counsel, Pfizer Inc, USA
Justin McCarthy, Senior Vice President and Associate General Counsel, Pfizer Inc, USA
In recent years, pharmaceutical companies have expanded clinical research in emerging markets around the world and increasingly involving populations that traditionally have had limited or no access to clinical trials (other than experimental treatments for communicable diseases). Trial sponsors can increasingly find well qualified investigators from Latin America, Eastern Europe, Asia and other non-European and non-North American regions. By identifying and including them in their trials, industry can build a strong presence in formerly under-served areas, accelerate trial enrollment, and maintain or improve data quality and scientific standards.
Read full paper
Subscribe to the IICJ